atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
atai Life Sciences (ATAI) Misses Q3 EPS by 1c; Reports Cash and Cash Equivalents of $430.3M
November 15, 2021 7:12 AM ESTatai Life Sciences (NASDAQ: ATAI) reported Q3 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.
... More